Thu, 20 Aug 2026
12:57:34 pm
Rudransh Sangwan
Published at: August 20, 2026, 11:10 AM
Synopsis
Kronox Lab shares hit 20% upper circuit after Indo Borax & Chemicals approved the acquisition of a 64.26% stake for ₹246 crore. Check the deal details, share price rise, acquisition price and outlook.

Shares of Kronox Lab Sciences surged 20% to hit the upper circuit at ₹186.19 on August 20 after Indo Borax & Chemicals approved the acquisition of a 64.26% stake in the specialty chemicals company. The development triggered strong buying interest in Kronox Lab, while shares of Indo Borax also gained more than 12% during the session.
The proposed transaction involves the acquisition of 2.38 crore equity shares from Kronox Lab's promoters. The deal is valued at ₹246 crore, with Indo Borax agreeing to acquire the shares at ₹103.22 per share.
The board of Indo Borax & Chemicals approved the execution of a share purchase agreement for acquiring 64.26% of Kronox Lab Sciences' share capital. The transaction will give Indo Borax control and voting rights exceeding 25% of Kronox Lab's voting share capital.
| Particular | Details |
|---|---|
| Company being acquired | Kronox Lab Sciences |
| Acquirer | Indo Borax & Chemicals |
| Stake to be acquired | 64.26% |
| Shares involved | 2.38 crore |
| Acquisition value | ₹246 crore |
| Acquisition price | ₹103.22 per share |
| Kronox Lab share price | ₹186.19 |
| Day's gain | 20% |
| Day high | ₹186.19 |
| Day low | ₹155.01 |
The acquisition is part of Indo Borax's strategy to diversify its portfolio into businesses that it considers to have stability and growth potential. The company also said it intends to develop and expand Kronox Lab's business following the transaction.
Loading chart...
The immediate trigger for the stock's sharp move is the proposed change in ownership. A strategic acquisition of a majority stake can attract investor attention because it may bring changes in management, business expansion plans and capital allocation.
Kronox Lab's shares rose to ₹186.19, up ₹31.03 or 20%, hitting the upper circuit. The stock also recorded NSE volume of around 58.57 lakh shares, indicating strong trading activity during the session.
One of the key points investors may notice is the difference between the announced acquisition price and Kronox Lab's market price.
| Metric | Value |
|---|---|
| Acquisition price per share | ₹103.22 |
| Current share price | ₹186.19 |
| Difference | ₹82.97 |
| Current price premium to acquisition price | 80.38% |
| Stake acquired | 64.26% |
The market price is substantially above the ₹103.22 per share price agreed for the promoter stake. This difference reflects the fact that the acquisition transaction and the stock's open-market price are separate components of the overall deal and market response.
Kronox Lab has recorded gains across several time periods, with the latest 20% jump adding to its recent momentum.
| Period | Return |
|---|---|
| 1 Day | △ 20.00% |
| 5 Days | △ 7.05% |
| 1 Month | △ 21.40% |
| 6 Months | △ 54.90% |
| 1 Year | △ 13.04% |
| 5 Years | △ 16.87% |
The stock's one month and six month performance shows that the latest rally comes after an already positive period of price movement. Investors may therefore watch whether the stock can sustain the gains after the immediate acquisition related excitement settles.
Kronox Lab Sciences operates in the specialty chemicals industry and manufactures high purity specialty fine chemicals for a range of end user industries. Its business exposure makes the company part of India's broader specialty chemicals manufacturing ecosystem.
Following the proposed acquisition, Indo Borax & Chemicals plans to nurture and expand Kronox Lab's business. The transaction could therefore become an important development for the company's future ownership structure and business strategy.
Indo Borax & Chemicals operates in the chemicals sector and has said that the Kronox Lab acquisition forms part of its long term portfolio diversification strategy.
The company intends to use the acquisition to expand its presence in a business with growth potential while working towards value creation for stakeholders. The proposed majority stake will also give Indo Borax significant influence over Kronox Lab's future direction.
Kronox Lab's immediate share price outlook is likely to remain closely linked to developments surrounding the proposed acquisition, including completion of the transaction and any subsequent changes to the company's strategy.
The stock has already gained 20% today and is trading at its upper circuit. Investors may therefore watch trading volumes, further corporate announcements and the company's post acquisition plans before drawing conclusions about the sustainability of the rally.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

FSSAI has directed Dabur India to stop selling several food products carrying "100%" claims, including honey, ghee, oils and apple cider vinegar.

Aditya Infotech shares rise 5% after Motilal Oswal initiates coverage with a Buy rating and ₹4,200 target, citing strong video surveillance growth,...

Power sector stocks face pressure after a brokerage downgrade, with target prices cut to ₹410 and ₹360 amid slower loan growth, weaker earnings...

PFC share price falls 2.66% as weak Q1 FY27 performance, lower disbursements, margin pressure and PFC REC merger uncertainty weigh on sentiment.

REC share price falls 2.37% to ₹329 as profit booking weighs on the PSU lender. Check REC financials, valuation, dividend yield, stock performance...